Need a cost effective and self-sufficient LV-producing cell line?
White paper
Development and Optimization of In-House Serum Free Suspension-Adapted 293T Cell Line for Lentiviral Vector Production to Improve Cell & Gene Therapy Manufacturing
Learn MoreSecondary Malignancies Following CAR-T Cell Therapy | What Could We Learn from the FDA Investigation?
Need earlier readouts for your CAR tonic signaling?
Posters
Early Detection of Tonic Signaling in Primary Human CAR-T Cells by Flow Cytometry
Learn More